Concepedia

Emanuel Schenck

ES

Statistics

Publications

10

Citations

735

H-Index

10

Active since

1994

Affiliations

Pfizer (United Kingdom)(Current)

Pfizer (United States)

Stanford University

Providence Portland Medical Center

Bloomberg (United States)

Emanuel Schenck is an author at Pfizer (United Kingdom) specializing in medicine, pathology, and endocrinology.

Publications per year

1994–2025

10

Publications

10

The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation

Janis M. Taube, Güray Aktürk, Michael Angelo et al. · Journal for ImmunoTherapy of Cancer · 2020 · 288 citations · Full text

, , +17

Epileptogenesis and Enhanced Prepulse Inhibition in GABAB1-Deficient Mice

Haydn M. Prosser, Catherine H. Gill, Warren D. Hirst et al. · Molecular and Cellular Neuroscience · 2001 · 282 citations

, , +14

Challenges of drug discovery in novel target space. The discovery and evaluation of PF-3893787: A novel histamine H4 receptor antagonist

Charles E. Mowbray, Andrew Bell, Nicholas Clarke et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 37 citations · Full text

, , +14

Effects of growth hormone overproduction on grip strength of transgenic mice

Eckhard Wolf, Rüdiger Wanke, Emanuel Schenck et al. · European Journal of Endocrinology · 1995 · 36 citations

, , +17

Resonance distribution in open quantum chaotic systems

S. Nonnenmacher, Emanuel Schenck · Physical Review E · 2008 · 24 citations · Full text

, , +15

1–5 of 10